Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment

BACKGROUND: Lung cancer is the leading cause of cancer‐related deaths. Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) are effective for advanced non‐small cell lung cancer (NSCLC) harboring EGFR mutations, some patients experience little or no response. The Glasgow...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasahara, Norimitsu, Imai, Hisao, Naruse, Ichiro, Tsukagoshi, Yusuke, Kotake, Mie, Sunaga, Noriaki, Kaira, Kyoichi, Maeno, Toshitaka, Asao, Takayuki, Hisada, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396379/
https://www.ncbi.nlm.nih.gov/pubmed/32495520
http://dx.doi.org/10.1111/1759-7714.13526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396379/
https://www.ncbi.nlm.nih.gov/pubmed/32495520
http://dx.doi.org/10.1111/1759-7714.13526

Ejemplares similares